A Blast from BIEL's Past circa 2005 Abdominoplasty

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
376
A Blast from BIEL's Past circa 2005

Abdominoplasty Post-Operative Pain Control With ActiPatch, Goh, Kimberley, MD

Grand Strand Plastic and Reconstructive Surgery Center, P.A.
Myrtle Beach, SC 29577

An abdominoplasty is one of the most painful cosmetic body contouring procedures we perform. Fear of post-operative pain has always been an obstacle for patients when considering an abdominoplasty. There is now a new, portable, lightweight and low cost way to decrease postoperative pain. The ActiPatch is a device which produces pulsed electromagnetic therapy that helps reduce swelling, relieve pain and enhance healing.*

I have been using the ActiPatch 500 for postoperative abdominoplasties for about six months and have been very impressed at its pain control. Prior to ActiPatch I had been using oxycodone and diazepam for postoperative pain control with intra-operative marcaine placed under the flap prior to emergence from anesthesia. The patients complained of significant pain and usually needed additional prescriptions for both pain and muscle relaxers within four days of surgery and often again at one week. Since using ActiPatch postoperatively I have not written a supplemental prescription for pain control and they have some left over. Their narcotic and medication needs have now decreased approximately seventy five percent.

Initially four patients were placed on ActiPatch for pain control after abdominoplasties. All patients had standard abdominoplasties with muscle and skin tightening; one had an augment performed as well. The charts were reviewed and interviews performed retrospectively to the physician to evaluate postoperative pain and narcotic use.

The first patient, A., was a 44 year old woman who had three full term pregnancies and several months of nursing. She complained of loss of breast fullness and a saggy abdomen. Physical exam revealed ptosis and pseudoptosis of her breasts and a lax abdominal wall, especially the upper abdomen, and loose skin on the upper and lower abdomen. She underwent a standard abdominoplasty and a bilateral subglandular breast augment. The breast augment was performed using a smooth round saline Mentor implant 350cc filled to 400cc in subglandular position through an inframammary incision. The abdominoplasty resected about 40 X 13 centimeters of skin, and the diastasis recti was corrected (about an eight centimeter plication). Fourteen cc of ¼% marcaine was placed under the flap at closure. As the patient was emerging from anesthesia the ActiPatch 500 was placed on the epigastrum and attached using its adhesive pad directly on the skin.

In recovery she needed one oxycodone for immediate postoperative pain. The evening of surgery she rested comfortably, and on her first visit on postoperative day one she came for her appointment wearing makeup with her hair styled and had minimal complaints of pain. She had been taking only one oxycodone every six hours because she was afraid that it would hurt, but had no complaints of abdominal pain. She had her oxycodone changed to mepergan because of nausea, but used very little her first week. She said she felt "she could have run a marathon" and could not believe how little pain she had.

Patient B was a 30 year old woman with two full term pregnancies who complained of a lax abdomen after multiple pregnancies and a previous cesarean section five years prior. She underwent a standard abdominoplasty. Of note is that she had undergone a scheduled knee surgery two days prior to her abdominoplasty in order to make her recovery simultaneous. At surgery she had a 14 X 46 centimeter skin resection and an eight centimeter tightening of her diastasis recti. Fifteen cc of ¼% marcaine was placed under the flap at closure. The ActiPatch 500 was activated and placed directly on the epigastrum after the wound was closed. In recovery she had one oxycodone given orally. The first evening postop she used less than one oxycodone and one diazepam every six hours. The first day postop she complained only of knee pain, and felt that the abdominoplasty was less painful than her previous cesarean section. She also came in wearing facial cosmetics and had her hair styled on her first day after surgery. Her first week post op she also used less than 20 each of diazepam and oxycodone.

Patient C was a33 year old nulliparous woman with a previous submuscular augment mastopexy who complained of inability to tighten her lower abdomen with diet and exercise. She underwent a standard abdominoplasty with resection of approximately 13 centimeter by 43 centimeter skin ellipse, and an eight centimeter diastasis recti plication. Postoperatively she had an ActiPatch 500 activated and applied to her epigastrum. In the recovery room she had one oxycodone orally for pain. The evening of surgery she took one and one 5 mg diazepam. By the evening of surgery her only pain was on moving to stand or recline. At rest she was pain free and reported less pain than her previous augment mastopexy. The following week she took one or two oxycodone a day.

Patient D was a 56 year old with one full term pregnancy who was interested in improving her saggy lower abdomen. She had a previous lower midline incision for a cesarean section and a right lower quadrant incision for a bone graft donor site. She had significant diastasis recti and a small abdominal pannus. She underwent a standard abdominoplasty with repair of diastasis and right lower quadrant plication for asymmetrical laxity. She had a 15 X 42.5 skin resection and a six centimeter plication. She had 12 cc of ¼% marcaine placed prior to emergence under the flap. Postoperatively she had one ActiPatch 500 device placed on the epigastrum. In the recovery room she had one oxycodone, and the first evening of surgery, one diazepam and one oxycodone. The next few days she was taking one to two diazepam once a day and one oxycodone four times a day. By the end of her first week she had taken about twenty of the oxycodone and even less of the diazepam.

The amount of pain relief with the ActiPatch after a major surgery is impressive. This retrospective review of patients' charts and interviews demonstrates a marked decrease in postoperative pain and use of narcotics in abdominoplasty. While the ActiPatch can assist with healing and reduce swelling, those benefits are difficult to appreciate in actual clinical practice. The amount of pain relief however is easier to evaluate. There is a marked decrease in the use of pain medications and as well as a significant increase in comfort level. It is currently a low cost, small, portable, narcotic free pain control device, and should be considered in all major abdominal surgeries.

Postoperative pain in an abdominoplasty is usually severe, and requires significant amounts of narcotics and muscle relaxers to control. The ActiPatch is a new device that suppresses pain without narcotics. It is a small, disposable, affordable and easily applied external device that is a radiofrequency generator. It has been promoted for decreasing swelling, accelerating wound healing (radiofrequency used in orthopedics to accelerate boney union) and for pain control. Byron Medical is the distributor for plastic surgeons.

I have found that using the ActiPatch for pain control has made a tremendous difference in my patients' recovery after an abdominoplasty. I now use it on all of my abdominoplasties. I started applying it to my abdominoplasty patients in 2003 and some of other patients who were concerned about postoperative pain control, and desired to be off medication sooner to be able to return to work. I have not been comfortable using the pain pumps, especially in those patients who have an implant because of the theoretical potential for introducing bacteria. This is a simpler, cleaner and less expensive way to approach surgical pain.

The response is impressive. I did a retrospective review of my abdominoplasty patients and looked at the number and amount of the pain medication prescriptions. I wrote for about one fourth of the usual amount if I used the ActiPatch. Prior to the ActiPatch they were using about two oxycodone and ten milligrams of valium every four hours the first few days. After I began using the ActiPatch, they were using about one fourth of the drugs in the first week. Also three of these abdominoplasty patients came to my office on the first day postoperatively with makeup on and their hair done. (The other did not wear makeup preop.) That was a first! I was using the ActiPatch 500 applied to the epigastrum in the operating room immediately after the procedure. I have also used it on my breast augment patients and reduction patients that seem to have a lower pain threshold, with good results.

I have had some of my abdominoplasty patients decide that their back bothered them more than their abdomen after a week or so and moved the ActiPatch from their abdomen to their back, and found relief. One got so much relief from her chronic back pain that she came back and bought three for a long trip to New Zealand! She has asked me if I mind her buying it for her back during the year.

ActiPatch for pain control is worthwhile in the postoperative patient, it allows less narcotic use. The cosmetic patient has a great appreciation for the earlier discontinuation of narcotics, and it should be considered for those procedures associated with significant postoperative pain.

https://www.sec.gov/Archives/edgar/data/13208...xh1014.htm page 49

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 7

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 6

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 8

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 5

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 6

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 7

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Rosewood HK Tops Best Hotel List Again; Asia Shines

Updated Category News Views 2

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Study Reveals New Insights into Knee Injuries

Updated Category News Views 368

Exploring Gender Differences in Knee Injuries Recent research sheds light on a surprising divide in knee injuries between men and women, bringing to the forefront new insights that could enhance treatment options. An extensive study conducted by Johns Hopkins Medical Institute involved 13,549 MRI evaluations of patients who presented with knee pain, revealing distinct...

Continue Reading
Commerzbank's Weidmann Discusses Challenges in UniCredit Merger

Updated Category News Views 326

Concerns Over UniCredit's Stake in Commerzbank In recent discussions, the chairman of Commerzbank's supervisory board, Jens Weidmann, has indicated a bleak outlook regarding the potential for an amicable merger with UniCredit. This comes in the wake of UniCredit's unexpected acquisition of a substantial stake in Commerzbank, creating ripples in the banking sector. Jens...

Continue Reading
FangDD Secures $34.3 Million to Expand Property Tech Framework

Updated Category News Views 164

FangDD's Noteworthy Financial Move Fangdd Network Group Ltd. (Nasdaq: DUO), a leading property technology firm based in China, has made an exciting announcement regarding its recent issuance of a convertible note aimed at enhancing its business operations and fulfilling payment obligations under an asset acquisition agreement. This significant step reflects FangDD's...

Continue Reading
Johnson & Johnson's Spravato Secures FDA Approval for Depression Treatment

Updated Category News Views 266

Johnson & Johnson Secures FDA Approval for Spravato In a significant development for mental health treatment, the FDA has greenlit Johnson & Johnson’s supplemental New Drug Application for Spravato (esketamine) nasal spray. This approval marks Spravato as the pioneering and sole monotherapy tailored for adults afflicted with major depressive disorder (MDD) who have not...

Continue Reading
Arlo Technologies' Equity Grants: Strengthening Team Dynamics

Updated Category News Views 106

Arlo Technologies Strengthens Workforce with Equity Incentives Arlo Technologies, Inc. (NYSE: ARLO), a prominent player in smart home security, is excited to share recent developments in its employment strategy. The company made equity grants to several new employees as part of its efforts to foster growth and ensure the best talent is onboarded effectively. Inducement...

Continue Reading